# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-042017
Filing Date
2021-08-12
Accepted
2021-08-12 16:07:50
Documents
90
Period of Report
2021-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | QUARTERLY REPORT | f10q0621_immucellcorp.htm iXBRL | 10-Q | 1086421
2 | CERTIFICATION | f10q0621ex31_immucellcorp.htm | EX-31 | 8137
3 | CERTIFICATION | f10q0621ex32_immucellcorp.htm | EX-32 | 4708
| Complete submission text file | 0001213900-21-042017.txt |  | 6300965

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL SCHEMA FILE | iccc-20210630.xsd | EX-101.SCH | 71750
5 | XBRL CALCULATION FILE | iccc-20210630_cal.xml | EX-101.CAL | 30451
6 | XBRL DEFINITION FILE | iccc-20210630_def.xml | EX-101.DEF | 286170
7 | XBRL LABEL FILE | iccc-20210630_lab.xml | EX-101.LAB | 571503
8 | XBRL PRESENTATION FILE | iccc-20210630_pre.xml | EX-101.PRE | 303188
9 | EXTRACTED XBRL INSTANCE DOCUMENT | f10q0621_immucellcorp_htm.xml | XML | 897837

Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12934 | Film No.: 211167556
SIC: 2835 In Vitro & In Vivo Diagnostic Substances